Induced Pluripotent Stem Cells—Derived Stem Cells: A Promising Tool for Disease Modeling
DOI:
https://doi.org/10.17140/GOROJ-8-158Abstract
Stem cells possess potential to undergo self-renewability giving rise to any cell type in the body known as pluripotency. This process, also known as differentiation, through which stem cells undergo several morphologic and genetic changes resulting in daughter cell lineages. The end point lineage depends on the growth and differentiation induction factors or proteins added to in vitro stem cell culture.
References
Marchetto MC, Brennand KJ, Boyer LF, Gage FH. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum Mol Genet. 2011; 20(R2): R109-R115. doi: 10.1093/hmg/ddr336
Ebert AD, Liang P, Wu JC. Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Phar-macol. 2012; 60(4): 408-416. doi: 10.1097/FJC.0b013e318247f642
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4): 663-676. doi: 10.1016/j.cell.2006.07.024
Li L, Chao J, Shi Y. Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases. Cell Tissue Res. 2018; 371(1): 143-151. doi: 10.1007/s00441-017-2713-x
Liang KX, Kristiansen CK, Mostafavi S, et al. Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mu-tations. EMBO Mol Med. 2020; 12(10): e12146. doi: 10.15252/ emmm.202012146
Joseph R, Bales K, Srivastava K, Srivastava O. Lens epithelial cells-induced pluripotent stem cells as a model to study epithe-Submit your article to this journal | https://openventio.org/submit-manuscript/ 20 Parasar P lial-mesenchymal transition during posterior capsular opacifi-cation. Biochem Biophys Rep. 2019; 20: 100696. doi: 10.1016/j. bbrep.2019.100696
Lipskind S, Lindsey JS, Gerami-Naini B, et al. An embryonic and induced pluripotent stem cell model for ovarian granulosa cell development and steroidogenesis. Reprod Sci. 2018; 25(5): 712-726. doi: 10.1177/1933719117725814
Cozzolino M, Marin D, Sisti G. New Frontiers in IVF: mtDNA and autologous germline mitochondrial energy transfer. Reprod Biol Endocrinol. 2019; 17(1): 55. doi: 10.1186/s12958-019-0501-z
Gulimiheranmu M, Wang X, Zhou J. Advances in female germ cell induction from pluripotent stem cells. Stem Cells Int. 2021; 2021: 8849230. doi: 10.1155/2021/8849230
Laronda MM, Burdette JE, Kim J, Woodruff TK. Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment. Stem Cell Res Ther. 2013; 4 Suppl 1: S13. doi: 10.1186/scrt374
McTague A, Rossignoli G, Ferrini A, Barral S, Kurian MA. Ge-nome editing in iPSC-based neural systems: From disease models to future therapeutic strategies. Front Genome Ed. 2021; 3: 630600. doi: 10.3389/fgeed.2021.630600 Opinion | Volume 8 | Number 1|
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
